jNet1

jNet1

TBA
22,411 Views
JNet1 is an ecosystem for jewelry businesses based on b2b and b2c IT-platforms with its own JnetCoin.
6.3
TOTAL SCORE
5.8
ICO PROFILE

(weight: 45%)

8
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Country: Russia
Token info
Ticker: jNetCoin
Platform: Waves
Available for sale: 10,000,000 jNetCoin
Financial
ICO Price: 1 jNetCoin = 0.0001 BTC
Accepting: BTC, ETH, Waves
January - May 2015
Preparation of idea
May 2015
Launch of the first stage of the IT platform jNET1 development
June 2016
Introduction of IT project to the jewelry market
July 2016 - May 2017
Marketing company
Q3-Q4 2017
Development of the functional and structure of new add-ins to the jNET1 platform
Q1-Q2 2018
Creation of a jewelry tracking system using jNET1-based blockchain technology
Screenshots taken on 3 Feb 2018
Ryzhevsky Evgeny
CEO, Founder
No participating data
Kaplun Dmitry
CBDO
No participating data
Timoshenko Dmitry
CTO
No participating data
Orlov Evgeny
CFO
No participating data
Dmitry Machikhin
Legal issues
No participating data
Peter Korda
International expansion of platform
No participating data
Anatoly Bordyugov
Investment consultant
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Blackfol.io
Blackfolio is the smartest social trading platform to manage your crypto wealth. Connected, supporting main exchanges and assisted by our artificial intelligence, we are building your futur every-day companion app. Accessible from desktop or mobile, you earn time and get a clear view of your profit & loss.
Upcoming
Libra Credit
CRED, formerly Libra Credit, is a decentralized lending ecosystem that facilitates open access to credit anywhere and anytime based on the Ethereum blockchain.
Upcoming
Emrify Health Passport
Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.
Upcoming
BUFF
By establishing a virtual gaming economy platform based on Blockchain technology, which will correlate in-game achievements with a rewarding mechanism, BUFF will enable gamers to accumulate coins in the background as they continue to play uninterruptedly, benefiting gamers with a new incentive to spend more time gaming, and opening a new marketing approach for game publishers to interact for longer time periods with gamers to increase loyalty to their brands.
Upcoming
Unchainet
UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.